Salient Bioscience
Marta Ciechonska is currently serving as the Co-Founder at Salient Bioscience since June 2020. Prior to this role, Marta worked as a Research Associate at London BioFoundry from April 2019 to September 2020. With a background in Microbiology and Immunology, Marta held the position of Postdoctoral Research Associate at both Imperial College London from August 2014 to January 2020 and Dalhousie University from September 2013 to May 2014. Marta obtained their Doctor of Philosophy (PhD) in Microbiology and Immunology from Dalhousie University in 2013 after completing their Bachelor of Science (B.Sc.) Hon in Microbiology at the University of Guelph in 2006.
This person is not in any teams
Salient Bioscience
Salient Bio is an innovative, fast-growing biotech start-up combining synthetic biology and robotics to build digital-first laboratories that make diagnostic testing available to all. We pride ourselves on the ingenuity of our automation, excellent customer service and agile approach to the market and our customers' needs. We believe in the power of preventive healthcare, and that access to diagnostic testing - both conventional and cutting edge - should be available to everyone. This is our North Star, and everything we develop is in service of our mission to deliver a world class diagnostics service and experience. We are based in central London, where we've built a state-of-the-art laboratory offering a wide range of diagnostic testing, both, routine and specialised, as well as operating an R&D microbiome laboratory undertaking cutting edge research. This represents the start of our journey to transform the delivery of mass-scale diagnostics to communities around the world. Contact us to learn more: info@salient.bio.